Proceedings of the National Academy of Sciences of the United States of America · 2025
The role of colony morphotype in shaping gene essentiality in Mycobacteroides abscessus.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ross Brittany N, Evans Emma, Diggle Frances, Briaud Paul, Whiteley Marvin
Аннотация
Changes in bacterial colony morphology are common during chronic human infections and are thought to provide a survival advantage. In the human pathogen Mycobacteroides abscessus (MAB), a unidirectional transition from a smooth (MABS) to rough (MABR) morphotype frequently occurs during chronic infection. This transition has profound clinical implications, as MABR induces a heightened proinflammatory response, contributing to increased morbidity. To better understand this phenomenon, we used transposon insertion site sequencing (Tn-seq) to identify genes essential for the survival of MABS and MABR. Our analysis revealed distinct genetic requirements for growth in vitro, including several genes involved in responding to environmental stresses. Notably, some of these uniquely essential genes are therapeutic targets in mycobacteria. In a murine infection model, the divergence in essential gene profiles between MABS and MABR was even more pronounced, driven partly by the differing host immune responses elicited by each morphotype. These findings demonstrate that the transition from a smooth to rough morphotype not only impacts MAB's survival strategies but also highlights the importance of considering morphotype-specific genetic and functional adaptations when developing therapeutic approaches. Our work underscores the critical need to incorporate morphotype conversion into the prioritization of drug targets, as targeting morphotype-specific vulnerabilities could improve treatment outcomes for infections caused by this pathogen.